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Toll-like receptor 5 (TLR5) is activated by bacterial flagellins and plays a crucial role in the first-line 
defence against pathogenic bacteria and in immune homeostasis, and is highly conserved in vertebrate 
species. However, little comparative information is available on TLR5 functionality. In this study, we 
compared TLR5 activation using full-length and chimeric TLR5 of various vertebrate species (human, 
chicken, mouse, pig, cattle). Chimeric TLR5 receptors, consisting of human transmembrane and 
intracellular domains, linked to extracellular domains of animal origin, were generated and expressed. 
The comparison of chimeric TLR5s and their full-length counterparts revealed significant functional 
disparities. While porcine and chicken full-length TLR5s showed a strongly reduced functionality in 
human cells, all chimeric receptors were functional when challenged with TLR5 ligand Salmonella FliC. 
Using chimeric receptors as a tool allowed for the identification of ectodomain-dependent activation 
potential and partially host species-specific differences in response to various enteric bacterial strains 
and their purified flagellins. We conclude that both the extra- and intracellular determinants of TLR5 
receptors are crucial for compatibility with the species expression background and hence for proper 
receptor functionality. TLR5 receptors with a common intracellular domain provide a useful system to 
investigate bacteria- and host-specific differences in receptor activation.
Toll-like receptor 5 (TLR5) is a crucial determinant of pathogen-host interaction and essential for immune home-
ostasis1–4. Bacterial flagellins of diverse bacteria are the molecular stimuli that ligate and activate TLR5 in various 
vertebrates5–9. TLR5 recognition of bacteria also contributes to non-infectious disease. In particular in the intesti-
nal tract of vertebrates, TLR5 mediates various functions such as shaping the microbiota and immune balance as 
well as contributing to metabolic tolerance4,10. Some bacterial species avoid TLR5 recognition by changing their 
flagellin protein primary sequence and by structural diversification11–14. These evolutionary adaptations might 
benefit their lifestyle as chronic pathogens, environmental colonizers or symbionts.
In general, the recognition of TLR5 ligands is followed by TLR5 receptor dimerization and subsequent inter-
action of their intracellular Toll-interleukin-1 receptor (TIR) domains with TIR domains of adaptor proteins, 
Myeloid Differentiation primary response protein 88 (MyD88) and TIR-domain-containing adapter-inducing 
interferon-β (TRIF)15, leading to the activation of host cell signaling pathways16,17. The MyD88-dependent intra-
cellular signaling cascade includes activation of mitogen-activated protein (MAP) kinases and NF-κB, leading to 
transcription and secretion of proinflammatory cytokines7,18–21. Feedback modulation of the signaling cascade 
after initial activation also leads to the expression and activation of inhibitory molecules of the pathway, such as 
Toll-interacting protein (Tollip)22, the induction of inhibitory miRNAs23 and to the degradation of Interleukin-1 
receptor-associated kinase 1 (IRAK-1)24, which, in a secondary line of signaling, dampens the proinflammatory 
response (for review:25).
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Previous studies have addressed the question of species-specific recognition of bacterial flagellins by differ-
ent vertebrate TLR55,26–29. These approaches mostly relied on heterologous expression systems, where different, 
mainly full-length TLR5 receptor variants were expressed in human cells or in stably transfected NF-ĸB reporter 
cell lines. These prior studies have produced conflicting conclusions concerning the activation potential of TLR5 
from different species, such as TLR5 of bovine origin29–31. It has thus far remained unclear which requirements 
have to be met for heterologous TLR5 in human cells to be properly expressed, localized and able to signal. 
Likewise, the use of chimeric Toll-like receptors including TLR5 in human cells5,32–35 has been restricted to few 
studies and has not yet been fully able to clarify the basis of signal transduction by flagellins and other TLR lig-
ands, which is needed to address the question of specific signal uptake via the TLR5 extracellular domain (ECD).
To address some of these open questions, we have expressed and functionally tested TLR5 from various ver-
tebrate species in human cells, either as heterologous full-length receptors or as chimeric receptors, consisting of 
intracellular (C-terminal) and transmembrane domain of human TLR5, fused to the extracellular (N-terminal) 
domain of animal origin (chicken, murine, porcine and bovine). The results of our study clarify some of the 
requirements necessary for the expression and functionality of these heterologous TLR5 receptors. Furthermore, 
we have used the newly established systems to compare the activation potential of the diverse TLR5 ectodomains 
in response to the intestinal pathogenic bacterial species Salmonella enterica and Campylobacter jejuni and their 
corresponding purified flagellins.
Results
Cloning and expression of TLR5 receptors of different vertebrate species in human cells. As 
a prerequisite for testing the activity of diverse vertebrate TLR5 receptors, we cloned the avian (chicken, Gallus 
gallus, chTLR5), murine (Mus musculus, mTLR5) and porcine (Sus scrofa, pTLR5) TLR5 de novo from cDNAs of 
respective cell lines (Tables S2, S3). The bovine (Bos taurus) TLR5 (bTLR5) was subcloned from a commercially 
available expression construct (see Methods) into the same expression vector pEF6-V514, used for the other TLR5 
constructs (Table S2), for functional comparison with TLR5 receptors from other species. The functionality of 
the human TLR5 (hTLR5) cloned in pEF6-V5 has been verified previously9,14. All TLR5 variants were equipped 
with a C-terminally fused V5 epitope tag for comparative detection by immunostaining. We transiently trans-
fected human cell lines with the full-length TLR5 constructs, carrying their original N-terminal signal peptides, 
and verified the expression of all receptor variants by immunoblotting. All TLR5 constructs were detected at the 
calculated molecular masses in the blots and were expressed to comparable amounts, both in human HEK293-T 
and HeLa cells (Fig. 1A,B). We then detected the localization of the expressed TLR5 variants in human cells 
in situ, after immuno-labeling of the common C-terminal V5 tag of all TLR5 variants, also using the specific anti-
V5-epitope antibody. The transfected cells were pre-screened for efficient fluorescent labeling by manual micros-
copy and then subjected to automated microscopy and immunofluorescence-based automated image acquisition 
and quantification of TLR5 expression. The subcellular distribution pattern of the different full-length vertebrate 
TLR5 receptors in human cells was similar (Fig. 1D). In addition, the automated intensity quantitation and aver-
aging of more than 100 TLR5-positive cells per construct determined that all full-length TLR5 receptors are 
expressed in similar amounts (Fig. 1E). These findings appeared to provide a suitable basis to perform compara-
tive functional assays on the various full-length TLR5 proteins in the same cellular background.
Functional testing of full-length TLR5 variants reveals reduced functionality of chicken and por-
cine TLR5 in human cells. In order to assess the activation potential of all expressed full-length TLR5 from 
different species, we next performed cytokine measurements in supernatants of non-activated versus flagellin(-
FliC)-activated cells (see Fig. S1, for purification of recombinant FliC flagellin). Various vertebrate TLR5 receptors 
showed differential activities towards the canonical ligand Salmonella FliC (Fig. 2). Mouse and bovine full-length 
TLR5 were highly activated, both in HEK293-T and in HeLa cells, to induce IL-8 secretion in the human cel-
lular background, in HeLa cells even significantly higher than the full-length human TLR5 (Fig. 2A). Chicken 
and porcine TLR5 receptors displayed significantly lower activation levels (IL-8 release) in HeLa (Fig. 2A) and 
HEK293-T (Fig. 2B) cells when compared to the other receptors and to full-length human TLR5, although they 
still showed a significant increase of IL-8 by FliC (Fig. 2B). Reduced activation potency of the chicken and porcine 
receptors for IL-8 secretion was more pronounced in HEK293-T in comparison to HeLa cells. When tested in 
control experiments, differential expression levels of TLR downstream signaling components MyD88, IRAK-
1, and IRAK-M were clearly detectable between the two human cell lines (Fig. S2). For instance, MyD88 was 
much higher expressed in HeLa cells. These clear-cut cell-specific characteristics provided a likely cause for the 
observed cell-specific activation differences, in particular the higher activation in the HeLa cells by chicken and 
porcine TLR5. Other control experiments excluded nucleotide differences in the promoter region, in the Kozak 
sites introduced by the cloning procedures, or an interference by the C-terminal V5 tag as being responsible 
for the differential activation potential of the full-length chicken TLR5 (Fig. S3). We therefore considered that 
potential species barriers between the non-human receptors (chicken and porcine) and the human cells are one 
possible explanation for the observed phenotype of their decreased function. For instance, diversity in the intra-
cellular TIR domain structure or the adjacent transmembrane segment of the respective TLR5 species variant 
may mediate incompatibilities to downstream adaptor proteins such as MyD88 in human cells.
The expression of TLR5 chimeras in human cells partially restored the functionality of chicken 
and porcine TLR5 ectodomain chimeras for IL-8 secretion and NF-κB activation. In order to 
address the question of such potential species barriers experimentally, we designed equivalent TLR5 chimeras 
of all previously tested TLR5 variants. These chimeric receptor constructs consist of the ectodomain (ECD) 
sequences of the diverse vertebrate TLR5 (chicken, mouse, porcine and bovine), fused in-frame with the 
sequences for transmembrane segments and intracellular domain (ICD) of human TLR5 (Figs 1C, S4). All TLR5 
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chimeras were efficiently and comparably expressed after transient transfection, as verified by Western blotting 
and immunofluorescence-based automated quantification (Fig. 1A,E). Also, their expression patterns in cells 
in situ were again similar when compared to the full-length TLR5 of all tested species. The downstream signaling 
potential of the TLR5 chimeras was further verified and compared to the full length receptors by measuring IL-8 
release. All chimeric receptors activated human cells efficiently and significantly to secrete IL-8 upon stimulation 
with Salmonella FliC flagellin (Fig. 2A). Therefore, we anticipated that these heterologous TLR5 ectodomain con-
structs, in contrast to the full length receptors, would be better suited to conduct comparative activation studies 
within one common cellular background.
To strengthen the basis for further functional assays, we quantitated in more detail the activation potential 
of all full-length TLR5 and all chimeric receptors. For this purpose, we performed NF-κB reporter assays with 
recombinant Salmonella FliC flagellin as reference ligand, both in a concentration-dependent manner (Fig. 3A,B), 
Figure 1. Expression of TLR5 in transiently transfected human cells is similar between TLR5 from different 
species. HeLa (A) or HEK293-T cells (B) were transiently transfected with adjusted amounts of plasmids 
per well coding for TLR5 receptors from different vertebrate species or for chimeric receptors (empty 
vector pEF6-V5: 200 ng, human (h) TLR5-V5: 100 ng for A or 200 ng for B, chicken (ch) TLR5-V5: 200 ng, 
chicken/human (ch/h) TLR5-V5: 100 ng, mouse (m) TLR5-V5: 100 ng for A and 200 ng for B, mouse/human 
(m/h) TLR5-V5: 100 ng, porcine (p) TLR5-V5: 200 ng, porcine/human (p/h) TLR5-V5: 100 ng, bovine (b) 
TLR5-V5: 200 ng, bovine/human (b/h) TLR5-V5: 200 ng). 48 h post transfection, cells were harvested and 
cleared lysates analyzed for TLR5 expression using anti-V5 antibody (A,B). Each construct was tested in at 
least three independent experiments. (C) Schematic depiction of chimeric TLR5 constructs aligned with 
hTLR5. ECD = extracellular domain. TM = transmembrane domain. TIR = Toll-interleukin-1 receptor 
domain. Numbers above the boxes designate the amino acids of respective TLR5. (D) HEK293-T cells were 
transiently transfected with human, chicken, murine, porcine, bovine and chimeric TLR5-V5 expression 
constructs (amounts see above), fixed, labelled with anti-V5 and anti-mouse Alexa FluorTM-488 antibody 
and analyzed by the automated microscope device Cytation 3 (Biotek). (E) Mean immunofluorescence 
intensity per cell, automatically determined and calculated for every construct; for each condition, 124 
cells were measured. Significant differences between hTLR5 and other constructs are indicated by asterisks 
(Student’s t-test, unpaired, two-tailed) as follows: **0.001 < p < 0.01; and ***p < 0.001, n.s. non-significant. 
The following numbers refer to the determination of transfection efficiencies (ratio of V5-positive divided by 
DAPI-positive[all] cells, in percent) of the automatic detection system: hTLR5 = 57.44%; chTLR5 = 55.5%; ch/
hTLR5 = 73.5%; mTLR5 = 67.76%; m/hTLR5 = 67.74%; pTLR5 = 50.72%; p/hTLR5 = 54.46%; bTLR5 = 47.61%; 
b/hTLR5 = 66.12%. Full-length and chimeric receptors of the same species show transfection efficiencies in a 
similar range.
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and during a time course (Fig. 3C,D), using HEK-Blue Null1 reporter cells, which allow high-throughput screen-
ing for NF-κB activation. The results of these experiments confirmed the reduced activation potential, in a 
concentration-independent manner, for full-length porcine TLR5 and full-length chicken TLR5 (Fig. 3A) at the 
level of NF-κB. The porcine/human (p/h) TLR5 chimera recovered significantly elevated NF-κB activation in a 
wide FliC concentration range (Fig. 3B). The chicken/human (ch/h) chimera recovered some (significant) acti-
vation potential, however only at higher FliC ligand concentrations (>10 ng FliC per well in a 96-well format) 
(Fig. 3B). During the time course experiment, the full-length chicken TLR5 did not show increased NF-κB acti-
vation after longer coincubation times with a fixed amount of FliC, while the porcine full-length TLR5 showed 
some, low-level, activation (significant) at later time points. Time-dependent NF-κB activation was restored for 
the ch/h and p/h TLR5 chimeras, although the maximal activation levels of those two chimeras in this setting still 
remained significantly lower than for the full-length human TLR5 (Fig. 3D). Bovine and mouse TLR5 chimeras 
showed a reduced NF-κB activation potential (maximum of absolute reporter induction values) in comparison 
to the respective full length receptors, for the dose-response experiment and during the time course. However, 
FliC-coincubated b/hTLR5 and m/hTLR5 still provided markedly elevated (highly significant) NF-κB activation 
in comparison to the mock-coincubated condition (Fig. 3B,D).
Functionality and intracellular signaling events of heterologous full-length TLR5 and TLR5 chi-
meras in human cells. All chimeric and non-chimeric constructs were compared with regard to different 
branches and downstream events of TLR5 signaling, namely p38 activation by phosphorylation and the degrada-
tion of IRAK-1, which is a feedback mechanism after successful docking of the TLR5 TIR domain to downstream 
adaptors36. As shown in Fig. 4, chicken and porcine TLR5 were clearly comfirmed to have a functional deficit in 
human cells, since they activated p38 poorly and did not lead to the degradation of IRAK-1 (Fig. 4A) upon stim-
ulation by Salmonella FliC (50 ng/well) for four hours. In contrast, all TLR5 chimeras activated both downstream 
pathways (Fig. 4B). In order to identify a potential molecular basis for the species barrier between chicken and 
Figure 2. Activation deficiency of chicken and porcine TLR5 can be partially rescued with respective TLR5 
chimeras. HeLa (A) or HEK293-T cells (B) were transiently transfected with adjusted amounts of plasmid DNA 
encoding for TLR5 from different species or chimeric receptors (transfected plasmid amounts see Fig. 1). 48 h 
after transfection, cells were coincubated with purified recombinant Salmonella FliC (50 ng/well) or mock-
treated for four hours. IL-8 secretion in the cell supernatants was determined by ELISA. IL-8 secretion of 
hTLR5-transfected, FliC-stimulated cells was set to 100% (reference); relative IL-8 secretion of all constructs with 
regard to the reference is depicted. Each condition was tested in two independent biological replicates (each in 
technical triplicates), the results of which are summarized here as mean and standard error. One representative 
experiment out of three is shown. For all constructs in A and B, except for pEF6-empty, the differences between 
mock-coincubated and FliC-coincubated condition were highly significant (Student’s t-test, unpaired, two-
tailed; p < 0.01). Likewise, all differences between the full-length and respective chimeric constructs (in A) 
in the FliC-coincubated condition were also highly significant (p < 0.01). For clarity, asterisks here indicate 
solely the significant differences between FliC-activated hTLR5 and the corresponding activated full-length or 
chimeric constructs (Student’s t-test, unpaired, two-tailed) as follows: *0.01 < p < 0.05; **0.001 < p < 0.01; and 
***p < 0.001, n.s. non-significant.
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Figure 3. Concentration dependency and time course of activation of NF-ĸB reporter cells expressing 
heterologous and chimeric TLR5 receptors from different vertebrate species by Salmonella FliC. HEK-Blue 
Null1 reporter cells were transiently transfected with adjusted amounts of plasmid DNA per well, encoding 
for full-length TLR5-V5 from different species, or with chimeric receptor constructs (empty vector pEF6-V5: 
100 ng; human (h): 50 ng; chicken (ch): 50 ng; chicken/human (ch/h): 50 ng; mouse (m): 100 ng; mouse/human 
(m/h): 50 ng; porcine (p): 100 ng; porcine/human (p/h): 100 ng; bovine (b): 100 ng; bovine/human (b/h): 
100 ng; 96-well format). 24 h post transfection, the cells were coincubated with different amounts of purified 
recombinant Salmonella FliC (1 ng to 200 ng per well) over a time course of 13 h. NF-κB-dependent SEAP 
production by the reporter cells was determined by colorimetric measurements at 620 nm (see Methods) and 
served to determine the optimal concentration and time parameters for further coincubation assays. Panels 
(A,B) show concentration-dependent activation of all non-chimeric (A) and chimeric (B) constructs. Panels  
(C and D) show time-dependent activation of all non-chimeric (C) and chimeric (D) constructs, all coincubated 
with 10 ng FliC ligand per well. Mean and standard deviation from technical triplicates of a representative 
experiment are shown. Significant differences between FliC-activated hTLR5 and the corresponding non-
chimeric and chimeric activated constructs are indicated by asterisks (multiple comparison by two-way 
ANOVA, Dunnett’s multiple comparison test of activation by 20 ng FliC in (A,B) and for the whole activation 
time course in (C,D) as follows: *0.01 < p < 0.05; **0.001 < p < 0.01; and ***p < 0.001, n.s. non-significant.
Figure 4. Comparative analysis of TLR downstream signaling after heterologous TLR5 activation indicates 
major contribution of intracellular domain in signaling deficiencies. HeLa cells were transiently transfected 
with indicated TLR5-V5 plasmids (transfected plasmid amounts as in Fig. 1) and subsequently activated with 
recombinant Salmonella FliC (50 ng/well) for four hours. Cleared cell lysates were analyzed by immunoblotting 
for posttranslational modification of p38 and degradation of IRAK-1. Phosphorylation (=activation) of p38 was 
visualized by a phospho-specific p38 antibody (α-P-p38) and is shown in comparison to the same blot probed 
with α-p38 antibody. Degradation of human IRAK-1 triggered TLR5 signaling was detected by an α-IRAK-1 
antibody (Table S6 for antibodies).
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human TLR5 receptors, respectively, one point mutation was introduced into full-length chicken TLR5 at amino 
acid position 746 in the C-terminal domain (R746 in chicken and Q744 in human TLR5) close to the BB loop, 
which has been shown to interact with downstream TIR domains of human MyD88 (Fig. S5). This residue is one 
of the few in this well-characterized segment of TLR5 receptors which is divergent between the heterologous 
TLR5 variants and human TLR5. This residue in full-length chicken TLR5 was changed to the human-specific 
amino acid, resulting in the site-mutated construct chTLR5(R746Q). Interestingly, this point-mutated TLR5 var-
iant was not expressed in detectable amounts in cleared lysates of transiently transfected human cells and did not 
recover functionality (Fig. S5). The lack of expression was accompanied by a massive phosphorylation of p38, sug-
gesting cellular endosomal stress activation, possibly due to a trafficking impairment that can lead to downstream 
stress signaling37. Two sequence polymorphisms in the ectodomain of the cloned full-length chicken TLR5 and 
the ch/h chimera were identified by Sanger sequencing in comparison to the reference sequence in the NCBI 
database (NP_001019757.1) (Suppl. Fig. S11). These exchanges were non-synonymous (aa 29D to V and aa 90 S 
to G), and localized far from the leucine-rich repeat 9 (LLR9) which directly interacts with the flagellin ligand17. 
For full-length porcine TLR5, complete plasmid sequencing verified that the coding region entirely matched the 
respective reference sequence (NP_001335700.1).
Reciprocal expression of selected TLR5 constructs in chicken cells verifies that human and chicken 
TLR5 are functional in chicken cells. In order to analyze chicken TLR5 functionality in more detail, 
since we suspected a potential species barrier, a reciprocal experimental approach was performed. The chicken 
macrophage-like cell line HD-11 or a stably transfected NF-κB HD-11 luciferase reporter line (HD-11_Luc38) 
were used for transient transfection with chicken TLR5, human TLR5 and the corresponding TLR5 chimera via 
nucleofection. Both human and chicken TLR5 were functional in the chicken cellular background, and activation 
with recombinant Salmonella FliC for two hours resulted in significantly enhanced transcript levels of chicken 
IL-8 and IL-1β cytokine genes (Fig. 5A,C) and stimulation of NF-κB (Fig. 5D). Moreover, expression and acti-
vation were comparable between the chicken and human full-length TLR5 constructs in HD-11 cells, demon-
strating compatibility of human TLR5 with chicken cells (Fig. 5A,C and E). Of note, nucleofection of HD-11_luc 
cells with chimeric TLR5 (chicken-human) resulted in a high background activation of NF-κB and enhanced 
cell death two days after nucleofection. Taken together, the reciprocal experiment suggests that chicken cells can, 
in principle, support, the activity of full-length human TLR5, while this is less the case vice versa. It cannot be 
excluded at present that this differential species-specific phenotype is associated with the respective cell or cell 
type (epithelial versus macrophage).
Various TLR5 chimeras are differentially activated by Salmonella enterica serovars or their puri-
fied flagellins. The constructed TLR5 chimeras offered the possibility to compare activation potential mostly 
dependent on the ECDs of TLR5 from different vertebrate species in response to flagellins of bacterial pathogens with 
different host adaptation phenotypes. Applying our chimeric test system, we next focussed on the investigation of 
TLR5 activation by the important human enteric pathogens Salmonella enterica (different serovars; Supplementary 
Table S1) and preselected, variable Campylobacter jejuni strains (Table S1). We compared ECD-dependent activation 
potential of various respective serovars (S. enterica) or strains (C. jejuni) on human (full length TLR5), or chicken, 
mouse, porcine and bovine TLR5 chimeras. With this aim, a reporter cell line (HEK-Blue Null1 SEAP reporter 
cells) for NF-κB-dependent activation, which is suitable for screening numerous ligands simultaneously in real 
time, was transiently transfected with full-length human or chimeric TLR5 constructs and activated using sonicated, 
homogenized bacterial lysates (Fig. 6). Interestingly, lysates of 24 different S. enterica isolates showed a differential, 
serovar-dependent activation potential in this system. Lysates of Salmonella serovars Choleraesuis and Typhi were 
highly activating stimuli on all TLR5 chimeras compared to the reference FliC, whereas lysates of S. enterica serovars 
Enteritidis and Infantis showed an overall lower, intermediate, activating phenotype in comparison to the reference. 
Isolates of S. enterica serovars Bovismorbificans, Typhimurium, Paratyphi A and Paratyphi B exhibited a comparable 
and very low activation potential in this setting using 100 ng of bacterial lysate per well. A higher activation by those 
latter Salmonella lysates was found to be concentration-dependent. This was confirmed for the activation of hTLR5 
by various amounts (500 ng to 3 µg) of S. Typhimurium lysate (Fig. S6B). For the single chimeras, TLR5 receptors 
with human and porcine ECDs resulted in higher activation levels with all of the analyzed Salmonella lysates, fol-
lowed by mouse and chicken chimeric receptors in the order of decreasing activation. Relative NF-κB activation of 
the bovine chimera was very low for the chosen lysate amounts with all tested Salmonella lysates in comparison to 
purified recombinant Salmonella FliC used as a reference.
In order to compare the amounts of flagellins in the selected Salmonella lysates, we performed immunoblotting 
of lysates using anti-E. coli flagellin antibody. Lysates of the respective different Salmonella serovars contained com-
parable amounts of flagellin (Fig. S7). Only S. Enteritidis B 554 and Salmonella Typhi lysates exhibited clearly lower 
flagellin amounts, despite the fact that both showed an overall strong activation with all chimeric TLR5 constructs. 
Flagellins from eleven selected serovars corresponding to some of the lysate preparations were subsequently purified 
as native proteins from the respective Salmonella strains and used in equalized amounts to activate human cells in 
the chimeric TLR5-expressing, SEAP-dependent human reporter cell system. In contrast to whole bacterial lysates, 
all of the purified flagellar fractions activated the tested chimeras to a comparable extent, independently of the 
analyzed serovar (Fig. 7A). No or only minor differences between the activation potential of the respective flagellar 
fractions were also confirmed at the level of secreted IL-8 (Fig. 7B). In line with these results, Sanger sequencing of 
phase one and two flagellins (flgJ and fliC genes), respectively, from the tested Salmonella serovars did not reveal 
sequence differences at positions known to be important for TLR5 activation (Figs S9 and S10). Some strains only 
possess either flgJ (e.g. B1050) or fliC (e.g. B2359) genes, serving as type-specific controls (Figs S9 and S10). Taken 
together, purified native Salmonella flagellins activated TLR5 variants in a rather equivalent manner, while diverse 
Salmonella strain lysates showed heterogeneous activity via TLR5.
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Low extent of cell activation via TLR5 chimeras by various Campylobacter jejuni strains from 
different origins or their isolated flagellins. C. jejuni flagellin has been reported to have a low activation 
capacity on TLR511,39,40. However, this has not been analyzed in a comparative setting for TLR5 from a variety of 
vertebrate species nor for various different C. jejuni strains. In order to analyze species-specific TLR5 activation 
by C. jejuni, bacterial lysates and flagellar fractions were generated and tested comparatively for activation of the 
TLR5 chimeras for 17 human and animal C. jejuni isolates preselected after molecular typing, and including the 
reference strain 11168. In contrast to the results found with Salmonella serovars, the tested C. jejuni lysates did not 
show a significantly enhanced NF-κB activation of the various chimeric TLR5 constructs (Fig. 6B), independently 
of the applied amounts. Concentration-dependent maintenance of low activation was further tested for C. jejuni 
lysates 73 and 75 (at 500 ng to 3 µg per well) and hTLR5 (Fig. S6B). In addition to the results obtained with bacte-
rial lysates, no significant activation at the level of NF-κB was detected using isolated flagellin-enriched fractions 
of the tested Campylobacter species in the setting of TLR5 chimeras expressed in HEK NF-κB reporter cells 
(Fig. 7C). To summarize the latter findings, C. jejuni flagellins and lysates of various well-characterized isolates, 
preselected for genetic diversity, were not active on any of the expressed TLR5 chimeras in comparison to the FliC 
reference, regardless of C. jejuni strain origin or molecular sequence type of the respective strains.
Figure 5. Reciprocal expression and functionality of human, chicken and chimeric TLR5 within chicken 
cellular background. Chicken HD-11 (A,B,C and E) or NF-κB reporter HD-11 cells (D) were nucleofected 
with expression plasmids coding for human (h), chicken (ch) or chimeric (ch/h) TLR5 from different species as 
indicated in the Methods. 24 h post nucleofection, selected wells were coincubated with purified recombinant 
Salmonella FliC (200 ng/well in 6-well plate format or 25 ng FliC in 96-well plate format). For quantitative 
RT-PCR, cells were stimulated for 30 min, and transcript amounts of chicken IL-8 (A,B) and IL-1β (C) were 
determined. Quantitated transcript values were normalized to respective chicken GAPDH transcript amounts 
and are presented in [%] relative to FliC-activated ch/hTLR5, set to 100%. In panel B, chIL-8 transcript 
induction in FliC-activated versus mock-coincubated non-transfected HD-11 cells is shown as fold induction. 
This result demonstrates a significant but considerably lower response of intrinsic chTLR5 in comparison to the 
activities provided by transfected TLR5 expression constructs shown in A and C. NF-κB-dependent luciferase 
activity was measured after 3.5 h of HD-11_luc stimulation using SteadyGlo luciferase assay (D). In D, the 
respective control values for all constructs (pEF6-V5 empty, hTLR5, chTLR5, ch/hTLR5) without FliC activation 
were subtracted from each FliC-activated value as background to yield the depicted activated end values for 
each construct in luminescence photon counts [C per s]. Mean and standard deviation from technical duplicates 
for transcriptional activation (A,C) and from technical triplicates for intrinsic TLR5 activity in HD-11 (B) 
and NF-κB-dependent activation (D) are shown. All experiments were independently repeated at least once, 
with similar outcomes. Significant differences between specific conditions are indicated by lines and asterisks 
in A, B, C and D (Student’s t-test; *0.01 < p < 0.05; ***p < 0.001; n.s non significant). Western Blot analysis 
for expression of TLR5 constructs using cleared lysates of nucleofected HD-11 cells (E). Immunoblotting was 
performed using anti-V5 or anti-actin antibody (loading control).
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Discussion
Toll-like receptors are key innate immune pattern recognition receptors (PRR) (for reviews see1,41,42. They are not 
only important for defence reactions of cells against invading pathogens, but also contribute to the establishment 
of an immune homeostasis in conjunction with the resident microbiota at different body sites3,4,43 and prevent 
excessive immune activation3,44–46. TLR5 is known to play a major role in mediating both of these tasks, espe-
cially with regard to anti-pathogen defence and stable colonization in the intestinal tract10,44,47. TLR5 signaling is 
therefore not only required for proper functionality of the innate arm of the immune system, but moreover con-
tributes to the development of adaptive mechanisms, in order to maintain the balance of motile members of the 
microbiota, reduce the immunostimulatory load in the gut44, and providing temporal stability to the microbiota 
composition10.
Of note, TLR5 is the only PRR so far that recognizes a specific bacterial protein, flagellin, which is the exposed 
subunit of the bacterial motility organelle, the flagellum8. Numerous intestinal bacterial species, pathogens as well 
Figure 6. Comparison between activation potential by lysates of various Salmonella enterica serovars (A) and 
Campylobacter jejuni (B) strains on TLR5 chimera-expressing NF-ĸB reporter cells. HEK-Blue Null1 NF-κB 
reporter cells were transiently transfected with appropriate amounts of expression plasmids coding for human 
TLR5-V5 or for chimeric receptors (empty vector pEF6-V5: 100 ng, human (h): 50 ng, chicken/human (ch/h): 
50 ng, mouse/human (m/h): 50 ng, porcine/human (p/h): 100 ng, bovine/human (b/h): 100 ng). The different 
TLR5 chimeric constructs are color-coded as indicated below the x-axis and in the graph. After 24 hours, 
transfected cells were coincubated with Salmonella enterica or C. jejuni lysates (100 ng total protein content per 
well) for 11 h; NF-κB-dependent SEAP production was determined by colorimetric measurements at 620 nm 
(see Methods). Values are depicted as relative values (in percent) to each corresponding construct activated by 
20 ng of recombinant FliC as reference, which was set to 100%. Empty vector-transfected cells activated by lysate 
were defined as background and subtracted for each strain separately. This evaluation does not allow a direct 
comparison between chimeras, but allows the direct comparison between different bacterial strains/serovars 
for each chimeric receptor, and of relative host activation patterns between strains. Activation by single strains 
of each serovar is separately highlighted by alternating white or grey background shading. Additionally, strain 
groups are subdivided according to their serovar or sequence type (ST, for C. jejuni isolates) by dashed lines; 
each serovar or strain group (ST) and the group-specific strain names (according to Table S1) are indicated 
above the bars and color-coded in the same color. Mean and standard deviation from biological triplicates of 
a representative experiment (out of two independent experiments) are shown. For C. jejuni, results for strain 
11168 are given as a reference.
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Figure 7. Comparison between activation potential by flagellar fractions of selected Salmonella serovars 
(A,B) and C. jejuni isolates (C) on chimeric TLR5 receptors. (A) HEK-Blue Null1 NF-κB reporter cells were 
transiently transfected with appropriate amounts of expression plasmids coding for human TLR5-V5 or for 
chimeric receptors (empty vector pEF6-V5: 100 ng, human (h): 50 ng, chicken/human (ch/h): 50 ng, mouse/
human (m/h): 50 ng, porcine/human (p/h): 100 ng, bovine/human (b/h): 100 ng). After 24 hours, transfected 
SEAP reporter cells were coincubated with Salmonella flagellar protein-enriched fractions (25 ng protein per 
well) for 11 h; NF-κB-dependent SEAP production was determined by colorimetric measurements at 620 nm 
(see Methods). Values are depicted relative to the activation of the corresponding construct stimulated by 20 ng 
of recombinant Salmonella FliC as reference, which was set to 100%. Background of empty vector-transfected, 
flagellin-activated cells was subtracted. (B) IL-8 release of HeLa cells (absolute values in pg per ml) transfected 
for human TLR5 and bovine-human TLR5 chimera was determined after 4 h of coincubation with Salmonella 
flagellin-enriched fractions (125 ng protein) or recombinant FliC as positive control (50 ng/well; grey bars) 
of cells transiently transfected for 48 h. For each condition, mean and standard error of biological duplicates 
measured in technical triplicates are shown. The experiment was independently repeated once with similar 
results. In (A,B), flagellins from Salmonella strains B554, 571 and B2486 are representative for FliC-only strains, 
while B815 and xy92 only express FljB. (C) Activation by C. jejuni flagellin-enriched fractions of chimeric 
TLR5-transfected HEK-Blue Null1 cells was determined as described for Salmonella flagellin in A. For (A,C), 
activation by single strains of each serovar is separately highlighted by alternating white or grey background 
shading. For (A,C), mean and standard deviation from biological triplicates of a representative experiment 
are indicated. Each serovar or sequence type (ST, for C. jejuni isolates) and names of the group-specific strains 
(according to Table S1) are indicated above the bars and color-coded in the same color. The different expression 
constructs are color-coded as indicated below the x-axis and to the right side of the graph (for panel A) or 
indicated below the x-axis (for panels B and C).
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as commensals, express flagella and can be recognized by TLR55,9,48. Evasion of TLR5 recognition by specific bac-
terial flagellins has been described11,13,14, which may be of relevance for chronic colonizing bacteria, pathobionts 
and pathogens of the gastrointestinal tract.
The importance of functional TLR5 for colonization resistance against pathogenic bacteria becomes appar-
ent in humans harboring TLR5 polymorphisms, which predispose to various infectious diseases49–51. Some 
non-synonymous polymorphisms within the coding sequence of human TLR5 affect its signaling capacity and 
human disease susceptibility52,53. Sequence polymorphisms in tlr5 and associated changes in functionality have 
been identified within various animal species54–57. Several non-synonymous polymorphisms in both the ECD or 
the ICD were described to attenuate TLR5 responses towards flagellin, demonstrated for both porcine (polymor-
phisms R148L and P402L)56 and canine TLR5 (polymorphisms C100T and T1844C)55. In contrast, other amino 
acid exchanges resulted in a higher activation and have been suggested to be linked to enhanced susceptibility 
to inflammatory bowel disease, as described for the canine TLR5 (polymorphism G22A)55. In passerine birds, 
a fixation of a non-functional TLR5 variant in combination with several independent pseudogenisation events 
of TLR5 has been reported54. Despite the clear general importance of TLR5, the reported variations in TLR5 
functionality at the level of host species populations or individual animal breeds complicate general conclusions 
about TLR5 signaling for a whole species and require further clarification and comparative approaches. In this 
context, we have clarified in the present study basic requirements for TLR5 receptor function across various 
vertebrate species and generated a system to investigate the contribution of TLR5 ECD variants to host- and 
pathogen-species-specific signal transduction and signal strength.
Several questions remain to be clarified with respect to the role of TLR5 in the immune response in different 
species. Most genomes of vertebrate species characterized to date contain one TLR5 gene copy58,59. Although 
mouse and human TLR5 have been characterized in some detail5,27, and a structure of zebrafish TLR5 dimer 
ligated with flagellin has been published17, detailed mechanisms of TLR5-dependent or -independent signaling 
by bacterial flagellins are not completely understood. Likewise, the expression, signaling, and role of TLR5 in 
vertebrate species other than human or mouse are poorly characterized. It is also largely unknown, whether 
host species-specific traits of TLR5 signaling may exist. In particular, the roles of the receptor transmembrane 
domains and intracellular domains have not been explicitly studied, including differences in the compatibility of 
intracellular TLR5 TIR domains with downstream adaptors (e. g. MyD88) between species. It is also insufficiently 
understood, whether various bacterial species can induce differential TLR5-mediated responses in a strain- or 
host-specific manner. In the present study, we have therefore examined how TLR5 variants from different host 
species support signaling in a comparative, heterologous host setting, and developed a cell-based test system to 
determine host specificity of various vertebrate TLR5 variants. This approach has helped us to elucidate that there 
are potential incompatibilities at the molecular level, which are determined by both, the receptor ECDs and ICDs, 
or even by both, ECD and ICD, in combination, that may impair the functionality of some vertebrate TLR5 in 
human cells. Functional deficiencies of some vertebrate TLR5 (porcine, chicken) in human cells were identified. 
This prompted us to also establish an expression system using chimeric TLR5 with various vertebrate ECDs fused 
to the intracellular domain of human TLR5. We validated the functionality of the chimeric test system, which 
served as an indicator of ECD-dependent ligand recognition, and subsequently compared the activation potential 
of various S. enterica and C. jejuni isolates and their flagellins in cells expressing the TLR5 chimeras.
Conflicting evidence has been reported for the functionality of bovine TLR5 variants when expressed in 
human cells29–31. One group observed no functionality of bovine TLR5 within the human HEK293-T cellular 
background, which could be partially restored by the substitution of phenylalanine to tyrosine at position 798 (aa 
798 F to T), suggested to be a putative binding site for phosphatidylinositol 3-kinase29,30). One other group suc-
cessfully activated native bovine TLR5 within human HEK293 cells by H7 flagellin from E. coli31,60. In our hands, 
wild-type bovine TLR5, which exhibited phenylalanine at position 798, was active when expressed in human cells 
(e.g. HEK293-T or HeLa). Differences between the studies might be explained by the different reporter systems 
used. We conclude from our comprehensive results that native bovine TLR5 (F798) is fully functional in human 
cells corroborating the latter studies31,60. Full-length porcine TLR5 showed functional defects within human cells 
which could be recovered in the porcine/human chimera. This result strongly suggested that incompatibility of 
the porcine receptor with the downstream human cellular system is largely restricted to the receptor’s ICD, which 
underscores the validity of the chimera approach.
Chicken (avian) TLR5 shows the largest deviation in sequence from other TLR5 of various mammals, both in 
the ECD and ICD domains (Fig. S8). We increased the functionality of the chicken TLR5 ECD in human cells by 
fusion to the human TLR5 intracellular TIR domain. This result appears to indicate some amino acid sequence 
incompatibility in the chicken ICD with downstream factors or adaptors in the human cells. Deficits might also 
be caused by differences in intracellular trafficking or signaling potential, e. g. by interplay between heterologous 
ECD, TM and ICD. It is also possible that frequent non-synonymous SNPs of chicken TLR5 (in our case, two 
non-synonymous SNPs in the cloned chicken TLR5 ECD distant to LLR9) might be involved in modulating the 
TLR5 signaling capacities, which might explain discrepancies to previous studies26,28. Another factor determining 
TLR5 functionality is the transmembrane protein UNC93B1 which interacts with TLR5 close to its TM domain 
and influences TLR5 trafficking and localization61,62. We are currently investigating whether incompatibility with 
heterologous UNC93B1 might influence the functionality of various vertebrate TLR5; however, results have not 
been conclusive, since the expression of UNC93B1 after transient transfection mediated a strong reduction of 
TLR5 amounts in human cells (own unpublished results). Clearly, further analyses will be required to elucidate 
many of the remaining aspects of TLR5 protein-protein interactions, within and across species.
In our study, the responses to a reference flagellin, recombinant Salmonella FliC, confirm and expand the pre-
viously reported5,27 existence of host-species specific disparities between various tested vertebrate TLR5s at the 
level of NF-κB signaling. The significant concentration-dependent differences observed between human TLR5 
and the chimeric receptors with regard to NF-κB activation might reflect amino acid differences within the TLR5 
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ECD, which may be responsible for altering direct interactions with the TLR5 ligand flagellin. In particular the 
amino acids 265 (chicken: T) and 275 (chicken and cattle: L) in LLR9, which were proposed to interact directly 
with flagellins of different bacterial species48, deviate in those two species from the TLR5 sequence of the other 
tested animal species. Despite this amino acid difference in LLR9, bovine TLR5 was fully functional. We cannot 
exclude that other sequence variation or variation in glycosylation between species in the ECDs outside of LLR9 
impact on TLR5 structure, functionality and signal perception strength. Differences of TLR5 signal output at 
the species level were less pronounced with regard to IL-8 secretion, which may be partially due to the temporal 
accumulation of IL-8. This underscores the importance of a multi-pronged approach to comprehensively analyze 
cellular signaling pathways downstream of TLRs.
Reports of host species-specific TLR5 responses to flagellins have been published before5,26-28. Previously pub-
lished comparative activation analysis of full length human, chicken and murine TLR5, carried out in heter-
ologous expression systems, including hamster or human cellular background, showed distinctive recognition 
abilities in dose-response assays using purified bacterial flagellins, with overall higher responses by murine and 
chicken receptors compared to human TLR5 for most flagellins5,28. Moreover, mutations of single residues within 
murine TLR5 itself have implicated certain amino acids in distinctive species-specific recognition5,28. Previously 
reported host species-specific differences in response to purified flagellin were reproducible between mouse and 
human TLR5 (more robust activation by mTLR55,27,28. Our present results for mTLR5 and hTLR5 dose-dependent 
activation support a similar conclusion. The divergent amino acid 268 between mouse (P) and human TLR5 (A), 
localized within the LLR9, was proposed to be responsible for the observed species-specific signaling differences5. 
Interestingly, this amino acid is also not conserved within the other tested vertebrate species (S for chicken, por-
cine and bovine TLR5). A prior study reported a species-specific difference comparing human and chicken TLR5, 
with a stronger response by chTLR528. We note that the previous study28 relied on one selective reporter system in 
stably transfected cells, and the observed host species-specific differences in response to purified flagellins were 
small. Further aspects complicating the comparisons with results from different studies are the use of expression 
constructs which replace the natural signal peptide of the receptor with an artificial signal peptide28 which can 
affect trafficking and localization. Furthermore, the high abundance of SNPs within the coding sequence of TLR5, 
especially of domesticated animal breeds, may affect receptor signaling capacity. For instance, the prior study 
noted above28 utilized a chicken TLR5 variant harboring seven polymorphisms within the extracellular domain 
of TLR5, largely at positions highly conserved between vertebrate species, which might explain the observed 
discrepancies with our present results. Answering questions regarding the affinities of physical binding of specific 
flagellins to specific TLR5 ECDs requires complex biochemical approaches using purified TLR5 domains which 
have not been achieved yet. The functional implications of abundant SNPs in chicken TLR5 and differences 
between signaling results reported by various laboratories will require more detailed clarifications, for which we 
have now provided some basic tools.
The chimeric TLR5 ectodomain constructs described in this study were expressed and functional in human 
cells and were used for all further experiments to minimize ICD-dependent disparities between host-species. 
Previous reports regarding serovar-specific activation by Salmonella flagellins included only two serovars, 
S. Enteritidis28 and S. Typhimurium5,28, which did not allow conclusions. In our settings, purified flagellins of 
various Salmonella serovars did not show strong strain- or host-species specific differences in activation poten-
tial. This result may indicate that TLR5 ECDs do not provide a large discriminatory potential for flagellins of 
different Salmonella serovars. This data will still need to be expanded by more detailed dose-dependent activation 
studies. Supportive of this hypothesis, sequencing of flagellin genes of the tested Salmonella isolates revealed high 
sequence conservation within the TLR5-activating regions (e.g. amino acids Q89, N100, I411, L415), used for 
mutational approaches of bacterial flagellins in previous studies5,27,28. Amino acid conservation at these sites was 
independent of flagellar phase status or bacterial serovar. Lower NF-ĸB activation found for human and chimeric 
TLR5 receptors by flagellar fractions from two S. Enteritidis strains require further investigation. In the future, 
the chimeric test system can be used to characterize the flagellin-dependent responses in more detail, including 
flagellins from other bacterial species.
In contrast to the homogeneous effects of purified Salmonella flagellins, TLR5-dependent cell activation with 
the corresponding bacterial lysates revealed striking differences. The Salmonella lysates provoked differential 
activation outcomes, depending on the respective TLR5 variant expressed. Our present results permit us to con-
clude that specific inhibitory mechanisms acting on TLR5 signaling must exist in certain serovars, which may 
down-modulate the cell-activating responses induced by flagellins in a host species-specific manner. Salmonella 
serovars may be able to modulate TLR5 signaling to different extents, by flagellin-independent mechanisms. 
Modulation and inhibition of TLR signaling according to our present results seem to be specific for the TLR5 
origin as well as Salmonella serovar-specific. Signal modulation could be dependent on bacterial outer membrane 
determinants or effectors of the virulence-associated Type III secretion systems, which might be accessible to 
enter the cells from bacterial lysates. Effectors such as TlpA (TIR-like protein A) or AvrA63,64 might mediate 
serovar-specific inhibition on TLRs, other TIR-domain containing adaptor proteins, or on NF-κB activation, 
respectively. This attractive hypothesis should be tested in the future.
Extending previous studies using only five different C. jejuni strains comparing activation of human and 
chicken TLR511,26,39,40, we examined 17 preselected diverse C. jejuni isolates, including strains isolated from 
human and animal origin. All 17 isolates provided very little activation potential in cells expressing the chimeric 
TLR5 constructs. This suggests that C. jejuni, independent of host species, does not activate cells to a large extent 
via TLR5 ectodomains of any of the tested host species. This corroborates previous results obtained in human 
reporter cells, which showed that C. jejuni evades TLR5 recognition, and, via different molecules including gly-
cans65,66 or the TLR5 ligand protein FlaC38, downmodulates TLR signaling. In line with these findings, purified 
flagellins of various selected C. jejuni isolates did not show ECD-dependent TLR5 activation of the tested verte-
brate species, which confirms and expands previous studies11,26,39,40.
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In conclusion, we have characterized signaling limitations for the expression of TLR5 variants from heter-
ologous species in human cells and established a test system for the functional characterization of ligands and 
signal transduction by host-specific TLR5 ectodomains. Salmonella serovars appear to inhibit TLR5 signaling in a 
strain-specific manner by flagellin-independent mechanisms, while C. jejuni variants or flagellins did not activate 
any tested TLR5. The established test system will serve in the future to characterize TLR5 signaling requirements, 
activation and inhibitory effects by diverse ligands and bacteria in more detail.
Materials and Methods
Bacterial strains and culture conditions. Cloning was performed in Escherichia coli strains DH5α, 
MC1061, XL1-Blue (NEB) NEB5α (NEB). For overexpression of proteins, E. coli strain BL21(DE3) was used. E. 
coli was cultured in Luria–Bertani (LB) broth (Difco™ LB Agar, Lennox, BD Biosciences, Heidelberg, Germany) 
or on LB plates containing 1.5% Bacto agar. When appropriate, ampicillin (500 mg/l) was added to the medium. 
For the differential activation of cells, lysates and whole bacteria of various S. enterica serovars (24 strains in total) 
and 17 C. jejuni strains (Table S1) were used. Bacterial strains were collected and characterized by molecular 
typing in-house at Hannover Medical School. C. jejuni were cultured at 37 °C under microaerobic conditions 
(10% CO2, 5% O2, 85% N2) in vented jars on blood agar plates (Blood Agar Base II, Oxoid, Wesel, Germany), 
supplemented with 10% defibrinated horse blood (Oxoid) and standard antibiotics (10 mg/l vancomycin, 3.2 mg/l 
polymyxin B, 5 mg/l trimethoprim, 4 mg/l amphotericin B), or in brain-heart infusion broth (Oxoid) with the 
addition of 2.5 g/l yeast extract (Merck, Darmstadt, Germany). Salmonella enterica were grown on Columbia agar 
plates, containing 5% sheep blood at 37 °C. For bacterial lysate preparations, bacteria were grown on plates for 
approximately 24 h before harvest.
Cell types and culture conditions. HEK293-T, HeLa or HEK-Blue Null1 cells (#hkb-null1, Invivogen) 
were used for transfection and coincubation assays and propagated in Dulbecco’s MEM (Biochrom, Berlin, 
Germany) supplemented with 10% [v/v] fetal bovine serum (FBS; Promocell). Growth medium of HEK-Blue 
Null1 cells was additionally supplemented with 100 µg/ml of zeocin as selective antibiotic. HD-11 chicken 
macrophage-like cell line used for nucleofection experiments was maintained in Iscove’s basal medium (IBM) 
supplemented with 10% [v/v] FBS. HD-11 cells stably transfected with the firefly luciferase gene under control of 
a NF-κB promoter were cultured in medium containing puromycin as selective antibiotic (5 g/liter). All cell lines 
were routinely kept at 37 °C in a 5% CO2 humidified atmosphere.
DNA methods and cloning of TLR5 expression plasmids. (Schematic shown in Fig. S4) DNA meth-
ods were performed according to standard protocols using enzymes purchased from New England Biolabs 
(NEB, Ipswich, NJ, USA), Invitrogen (Carlsbad, California, USA) or Roche (Basel, Switzerland). Taq polymer-
ase (Roche), Phusion polymerase (NEB) or Q5 polymerase (NEB) were used for PCRs. TLR5 genes from dif-
ferent species (human, mouse, chicken, pig and cattle) were PCR- amplified using primers listed in Table S3. 
Specifically: amplification of the entire mouse TLR5 was achieved by mTLR5_F2 and mTLR5_R2 primers and 
J774 cDNA (Mus musculus; balb/c mouse) as template. Complete chicken TLR5 was amplified by chTLR5_F1 and 
chTLR5_R1 primers and HD-11 cDNA as template (chicken [Gallus gallus] breed: Polish Bantam), and complete 
pig TLR5 by piTLR5_F1 and piTLR5_R1 primers and template cDNA from IPEC-J2 cells (porcine [Sus scrofa] 
breed: German Landrace). All of the amplified TLR5 genes were cloned into pEF6-V5 expression vector (Novagen 
modified from14) using appropriate restriction enzymes. Bovine TLR5 was recloned from commercially available 
pUNO1-bTLR05 plasmid (Invivogen, # puno1-btlr5; bovine [Bos taurus] breed: Holstein) into pEF6-V5 vec-
tor using boTLR5-BstXI and boTLR5_NotI_R2 primers. Sanger sequencing technology was applied for precise 
sequencing of the complete cloned plasmids to verify sequence accuracy (used primers depicted in Table S4; 
complete alignment of amino acid sequences of all full-length TLR5 clone inserts in Fig. S11). Additionally, chi-
meric TLR5 receptors containing extracellular domains of animal origin, linked to a human intracellular domain 
were designed and generated. Gene sequence coding for extracellular domains of TLR5 receptors from different 
animal species were PCR amplified using the following primers (see also Table S3): mouse: mTLR5_F2 mTLR5_
R4; chicken: chTLR5_F1 and chTLR5_R2; pig: piTLR5_F2 and piTLR5_R2 and cattle: boTLR5_BstXI_F and 
boTLR5_BsaI_R. These amplified and correspondingly digested gene fragments were ligated to gene sequence 
coding for the intracellular domain of human TLR5 using an integrated AflII restriction site. The connection 
point of ECD and ICD domains was placed within the transmembrane part of the receptor (see Figs 1; S4) and 
leads to very few, mostly conservative amino acid exchanges (ch/h: none; pi/h: none; m/h: aa 651 Arg → Thr, aa 
652 Ser → Gly, aa 653 Leu → Thr; bo/h: aa 636 Glu → Ser, aa 637 Ser → Gly, aa 638 Leu → Thr). The expres-
sion of all cloned receptors was controlled by Western Immunoblotting and Immunofluorescence (see Fig. 1). 
Exchanges of single nucleotides within plasmids, leading to site-directed amino acid exchanges, were generated 
by usage of Quick Change Site-Directed Mutagenesis Kit (Agilent) or Q5 kit (NEB) according to the manufactur-
ers’ instructions (used primers listed in Table S5).
Transient cell transfection or nucleofection with plasmid DNA and protein expression analysis. 
HEK293-T or HeLa cells were seeded in 24-well plates and HEK-Blue Null1 cells in 96-well plates. Cells were 
used for transfection experiments at 60% confluency. 30 min before transfection, the medium was changed to 
0.5 ml (24-well plate) or 50 µl (96-well plate) OptiMEM medium (Gibco) containing 5% fetal calf serum (FCS). 
Indicated amounts (usually 200 to 50 ng) of plasmids of interest (Table S2 for plasmids used in this study), which 
were prepared by endo-free plasmid Midi-Kit (Qiagen, Hilden, Germany), were transfected using Lipofectamine 
2000TM (Invitrogen) according to the manufacturer’s instructions. Nucleofection of HD-11 cells was performed 
according to manufacturer’s instructions as for murine RAW264.7 cells using the SF cell line 4D-Nucleofector Kit 
(Lonza), and 4D-Nucleofector Device (Lonza) and 400 ng per well (24-well plate) or 2 µg per well applied DNA 
www.nature.com/scientificreports/
13SCIentIFIC REPORTS |  (2018) 8:11287  | DOI:10.1038/s41598-018-29371-0
(6-well plate). Further incubation for 24 h or 48 h allowed the expression of transfected or nucleofected constructs 
(as indicated in main text and figure legends). Cell lysis and harvesting was performed directly within the wells on 
ice using modified radio-immunoprecipitation assay (RIPA) buffer (50 mM Tris-HCl, pH = 7.5, 150 mM NaCl, 
1% Triton X-100, 1 mM EDTA, 1 mM EGTA, protease inhibitor cocktail Complete (Roche), phosphatase inhibitor 
cocktail PhosStop (Roche)). Analyses by Western immunoblotting were carried out for all human cell lines and 
HD-11 chicken cells to verify the protein expression levels of all constructs. For HD-11 cells nucleofected with 
plasmids, tlr5 transcripts were also tested using cDNA and qPCR. The transcript amounts of the three trans-
fected tlr5 variants htlr5, chtlr5, ch/htrlr5 were found to be comparable in this setting by qPCR. Intrinsic tlr5 was 
expressed in HD-11 cells, but at about 17-fold lower amounts (qPCR) than chtlr5 transcript expressed from a 
transfected chTLR5 plasmid. Intrinsic TLR5 led to about 2.5-fold increase in chIL-8 transcript (Fig. 5B), while 
transfected chTLR5 plasmid led to an about 6-fold increase in the same setting.
Protein methods. Protein amounts were determined by bicinchoninic acid (BCA) Protein Assay (Thermo 
Scientific - Pierce, Rockford IL, USA) and protein analysis was achieved by separation on denaturing 12% 
sodium dodecyl sulphate (SDS) polyacrylamide gels and Western immunoblot detection according to standard 
methods67. Equal amounts (usually 30 µg) of protein were loaded on each gel lane. Antibodies for labeling are 
indicated in the corresponding results and listed in Table S6. Immuno-reactive bands were visualized by Super 
Signal West Pico chemiluminescent substrate (Pierce, Thermo Scientific, Bonn, Germany) and ECL hyperfilm 
(GE Healthcare, Piscataway NJ, USA). Additional normalization of gel loading was performed against the cor-
responding loading controls visualized by using anti-actin antibody (Chemicon, MAB1501; mouse monoclonal 
antibody; used at a 1:30,000 dilution). In the case of sequential antibody application, membranes were stripped 
with Restore™ Western Blot Stripping Buffer (Thermo Scientific – Pierce).
Recombinant expression and purification of S. enterica serovar Typhimurium FliC. Expression 
and purification of S. enterica serovar Typhimurium FliC was performed according to our own published 
work14,38. For coincubation experiments of eukaryotic cells with purified flagellin, FliC was additionally puri-
fied by elution of the protein from an SDS gel in an Electro Eluter (Model 422, Bio-Rad, Munich, Germany). 
Eluted protein was dialysed several times against cell culture grade PBS using dialysis cassettes (Slide-A-Lyzer, 
MWCO 3.500 cut-off, Thermo Scientific). Purity and amounts of ultrapure recombinant flagellin were checked 
on Coomassie blue-stained SDS gels (see Fig. S1). Limulus assays (LAL chromogenic endpoint assay; Cambrex) of 
recombinant flagellins prepared by this method did not detect LPS above the detection limit of 1 endotoxin unit 
(EU) per μg of protein14, so that we do not expect contamination by other TLR ligands. Ultrapure flagellin was 
sonicated (1 min at 4 °C, power 5) in solution to expose the monomers, before all cell coincubations.
Bacterial lysates and preparation of flagellar fractionations. Whole cell lysates were generated from 
bacteria grown for 1.5-2 d on blood agar plates and resuspended in NaCl (0.9%). Lysis was achieved via sonication 
(Branson Sonifier) 3 times for 3 min.
For flagellar fractions, one day-old bacteria (in post-exponential phase, when abundant extracellular flagella 
have been formed), grown on the corresponding blood agar plates, were resuspended in 0.9% NaCl at an O.D.600 
of 4 to final volume of 500 µl. Surface-associated proteins including flagella proteins were sheared off the bacteria 
by repeatedly (30 times) pushing the bacterial suspension through a 23-gauge needle. Separation from bacterial 
cells was achieved by differential centrifugation: 20 min at 9,000 × g, 4 °C, followed by ultracentrifugation for 1 h, 
40,000 rpm, at 4 °C (Beckman Optima 100 ultracentrifuge). Surface-associated proteins were resuspended in Tris 
buffer (100 mM Tris-HCl, pH = 7,5). Enriched isolated flagellins were verified by Western immunoblotting using 
an anti-E. coli-flagellin antibody (Table S6; this antibody reacts strongly to Salmonella and Campylobacter flagel-
lins and reveals exclusively the flagellin bands in Western immunoblots), and protein amounts were determined 
by comparison to a bovine serum albumin (BSA) standard on SDS PAGE.
Coincubation of eukaryotic cells with recombinant flagellins, bacterial lysates or flagellin-enriched 
bacterial fractions. For coincubation experiments with purified flagellins or bacterial lysates, cells were 
seeded onto 96- (2 × 104 cells in 100 µl per well), 24- (2 × 105 cells in 1 ml per well) or 6-well plates (1 × 106 cells 
in 3 ml per well) 24 h prior to the coincubation. Media were replaced 30 min before the coincubation starting. 
Flagellins and lysates were sonicated (1 min at 4 °C, power 5, in a Branson sonifier) shortly before the coincuba-
tions to release monomeric flagellin and disperse the suspensions well. Activation potential of purified flagellins 
or bacterial lysates on TLR5 receptors from different species was tested by coincubation of TLR5-transfected cells 
with various amounts of ultrapure and sonicated FliC (1 to 200 ng per well), bacterial lysates (100 ng per well) 
or flagellin-enriched bacterial surface-fractions (25 ng per well) for 4 h to 12 h. Optimal time frame and concen-
trations were determined by time- and concentration-dependent measurements (Fig. 3) and regression analysis 
(Fig. S6A). Activation of NF-κB was determined using HEK-Blue Null1 reporter cells in 96-well plate format. 
NF-κB-dependent production of secreted embryonic alkaline phosphatase (SEAP) was detected by application 
of HEK-Blue Detection Medium (Invivogen), which allows real-time detection of produced SEAP amounts by 
colorimetric measurements at 620 nm. NF-κB-dependent activation of single TLR5 receptors by bacterial lysates 
and bacterial flagellin-enriched fractions is always depicted relative to a respective reference, which is the corre-
sponding TLR5-V5 construct activated by 20 ng of the reference flagellin (recombinant Salmonella FliC) and set 
to 100%. Background activation of empty vector-transfected and analogous lysate- or flagellin-activated cells was 
subtracted in order to obtain a TLR5 signaling specific read-out. We determined the expression of the TLR5 var-
iants to be similar and comparable in HEK-Blue cells under the same transfection settings as in HEK293-T cells. 
For the analysis of NF-κB-mediated activation of chicken cells, stable luciferase HD-11 reporter cells were stimu-
lated in a 96-well plate format and analyzed using SteadyGlo assay (Promega). HEK293-T or HeLa cells in 24-well 
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plate format were used for transfection and subsequent coincubation experiments and for further quantitative 
analysis of cytokine secretion (IL-8). IL-8 in supernatants of activated cells was determined by a commercially 
available ELISA (IL-8 OptEIATM ELISA system, Becton Dickinson, Inc, BD Biosciences), according to the manu-
facturer’s recommendations. 6-well plate format was chosen for experiments with subsequent RNA preparations 
and RT-PCR analysis.
RNA preparation and quantitative real-time (RT) PCR. RNA from nucleofected HD-11 cells was iso-
lated as already described38. DNAse I treatment of the isolated RNA was performed with Turbo DNA-free Kit 
(Ambion) according to manufacturer’s instructions. 1 µg of total DNA-free RNA was used for cDNA synthe-
sis with Superscript III reverse transcriptase (Invivogen) and oligo(dT) primers (Invivogen). 1 µl of synthesized 
cDNA was used for quantitative RT-PCR based on SYBR green (Qiagen) chemistry. Normalisation of the results 
was carried out according to transcriptional expression of chicken glyceraldehyde-3-phosphate dehydrogenase 
(chGAPDH). All primers used for RT-PCRs are listed in Table S7. RT-PCR reactions were performed in a Bio-Rad 
thermocycler (Bio-Rad C1000/CFX96 combined system) with following cycling conditions: denaturation for 
10 min at 95 °C, amplification for 40 cycles at 95 °C for 15–45 s, 15 s at an annealing temperature optimized indi-
vidually for each primer pair, 30 s at 72 °C. The expression of TLR5 variants after transfection was also probed 
at the cDNA level using qPCRs. It confirmed comparable tlr5 transcript amounts of the hTLR5-, chTLR5- and 
ch/hTLR5-transfected HD-11 cells, while the non-transfected HD-11 cells had about 16-fold lower amounts of 
intrinsic tlr5 transcript.
Immunofluorescence-based automated quantification by Cytation 3. For expression-analysis 
of different TLR5 constructs, HEK293-T cells were seeded onto coverslips coated with 0.3% gelatin and trans-
fected with TLR5-coding plasmids using Lipofectamine 2000TM. Two days later, cells were fixed with 2% para-
formaldehyde in potassium phosphate buffer (pH = 7) two times for one h, followed by a quenching step with 
quenching buffer (0.1% glycine in PBS) over night at 4 °C. Afterwards, cells were washed three times with PBS, 
then blocked and simultaneously permeabilized for 30 min in buffer containing 1% BSA, 1% goat serum, 0.05% 
saponine, in PBS. Anti-V5 (1:500) primary antibody was applied over night at 4 °C in PBS containing 1% BSA 
and 1% FCS. After washing the cells three times using washing buffer (PBS with 0.1% BSA), secondary anti-
body goat anti-mouse Alexa FluorTM 488 (1:5,000) was applied in PBS with 1% BSA and 1% FCS for 30 min at 
room temperature. Cells were repeatedly washed again and finally counterstained for the nucleus with DAPI 
(1:5,000, Sigma-Aldrich) for 15 min. The coverslips were mounted using Mowiol 4–88 (Merck) supplemented 
with 2.5% DABCO (Sigma-Aldrich) on microscope slides. Anti-V5 antibody staining was always negative on 
non-transfected or empty-vector transfected cells. The green fluorescence channel was compensated for autoflu-
orescence using non-transfected cells. Automated fluorescence microscopy for cellular expression analysis was 
performed using Cytation 3 Cell Imaging Multi-Mode Reader (Biotek) using constant, compensated, settings 
for the green fluorescence detection channel for all constructs (LED intensity: 10; Integration time: 136; Camera 
gain: 15.6) and the following cellular identification parameters (minimal size: 18 µm; maximal size: 34 µm, inten-
sity threshold in the green fluorescence channel: 3,000). Automatically recorded doublet cells were excluded 
manually. Cells were also semi-automatically evaluated for nuclei(DAPI)-positive (all cells) versus nuclei and 
Alexa488-positive (green) cells, to determine the transfection efficiencies for each TLR5 construct. The transfec-
tion efficiencies were determined to be as follows:
hTLR5 = 57.44%; chTLR5 = 55.5%; ch/hTLR5 = 73.5%; mTLR5 = 67.76%; m/hTLR5 = 67.74%; 
pTLR5 = 50.72%; p/hTLR5 = 54.46%; bTLR5 = 47.61%; b/hTLR5 = 66.12%. Full-length and chimeric receptors 
of the same species show transfection efficiencies in a similar range.
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